FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 28.27

Change

-0.80 (-2.75)%

Market Cap

N/A

Volume

0.26M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-1.42 (-1.10%)

USD 19.16B
VOT Vanguard Mid-Cap Growth Index ..

-1.85 (-0.71%)

USD 16.53B
IJK iShares S&P Mid-Cap 400 Growth..

-0.21 (-0.24%)

USD 9.61B
XMMO Invesco S&P MidCap Momentum ET..

+0.38 (+0.31%)

USD 4.68B
IVOG Vanguard S&P Mid-Cap 400 Growt..

-0.30 (-0.27%)

USD 1.15B
CWS AdvisorShares Focused Equity E..

+0.51 (+0.77%)

USD 0.18B
ETHO Amplify ETF Trust

-0.39 (-0.65%)

USD 0.18B
IPO Renaissance IPO ETF

-0.86 (-1.98%)

USD 0.16B
BFOR Barron's 400 ETF

-0.08 (-0.12%)

USD 0.16B
PEXL Pacer US Export Leaders ETF

-0.44 (-0.89%)

USD 0.05B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.12% 56% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.12% 56% F 28% F
Trailing 12 Months  
Capital Gain 2.54% 19% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.54% 19% F 29% F
Trailing 5 Years  
Capital Gain -12.94% 6% D- 30% F
Dividend Return 2.64% 17% F 6% D-
Total Return -10.30% 6% D- 17% F
Average Annual (5 Year Horizon)  
Capital Gain -1.25% 11% F 26% F
Dividend Return -0.56% 11% F 18% F
Total Return 0.69% 61% D- 17% F
Risk Return Profile  
Volatility (Standard Deviation) 30.05% 22% F 35% F
Risk Adjusted Return -1.86% 11% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.